Rhinocort Aqua versus Placebo and Fluticasone Propionate

Study identifier:D5360C00005

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-group, Phase IIIb study to assess the efficacy, safety & Product attributes of Rhinocort Aqua(Budesonide) versus placebo and FluticasonePropionate as an active comparator in patients 12yrs age &older with SeasonalAllergicRhinitis

Medical condition

Seasonal Allergic Rhinitis

Phase

Phase 3

Healthy volunteers

No

Study drug

Budesonide, Fluticasone propionate, Placebo

Sex

All

Actual Enrollment

750

Study type

Interventional

Age

12 Years +

Date

Study Start Date: 01 Apr 2003
Primary Completion Date: 01 Jul 2003
Study Completion Date: 01 Jul 2003

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria